Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy

Neurology

Volumn 57, Issue 1, 2001, Pages 115-121

  Hayashi, Yukiko K ^a   Ogawa, M ^a   Tagawa, K ^a   Noguchi, S ^a   Ishihara, T ^c   Nonaka, I ^b   Arahata, K ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c Higashisaitama National Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROGLYCAN; BETA DYSTROGLYCAN; CELL SURFACE PROTEIN; DYSTROGLYCAN; ENZYME; FUKUTIN; GLYCOLIPID; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BRAIN MALFORMATION; CHROMOSOME 9Q; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; GENE MUTATION; HEART MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFANT; MUSCLE FIBER MEMBRANE; MUSCULAR DYSTROPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN GLYCOSYLATION; SKELETAL MUSCLE;

EID: 0035838362     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.1.115     Document Type: Article

References (32)

1. Human dystroglycan: Skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization
2. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
3. Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor
4. A role for dystroglycan in basement membrane assembly
5. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins
6. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan
7. Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathological considerations
8. Abnormal localization of laminin subunits in muscular dystrophies
9. Electron microscopic examination of basal lamina in Fukuyama congenital muscular dystrophy
10. Fukuyama-type congenital muscular dystrophy: Close relation between changes in the muscle basal lamina and plasma membrane
11. Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetus
12. Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy
13. Breached cerebral glia limitans-basal lamina complex in Fukuyama-type congenital muscular dystrophy
14. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
15. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction
16. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy
17. Dissociation of the dystroglycan complex in caveolin-3 deficient limb girdle muscular dystrophy
18. A dystrophin-associated glycoprotein, A3a (one of 43DAG doublets), is retained in Duchenne muscular dystrophy muscle
19. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy
20. Immunocytochemical analysis of dystrophin in congenital muscular dystrophy
21. Dystrophin-associated glycoprotein and dystrophin co-localisation at sarcolemma in Fukuyama congenital muscular dystrophy
22. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide
23. Duchenne muscular dystrophy: Deficiency of dystrophin-associated proteins in the sarcolemma
24. Dystroglycan in the cerebellum is a laminin α2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells
25. Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties
26. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
27. The fukutin protein family - Predicted enzymes modifying cell-surface molecules
28. Dystrophic phenotype induced in vitro by antibody blockade of muscle α-dystroglycan-laminin interaction
29. Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse
30. α-dystroglycan functions in acetylcholine receptor aggregation but is not a coreceptor for agrin MuSK signaling
31. Abnormality of cerebral gangliosides in Fukuyama type congenital muscular dystrophy
32. Cortical dysplasia in a 23-week fetus with Fukuyama congenital muscular dystrophy (FCMD)